DCTH REKT Alot Of People

NASDAQ:DCTH   Delcath Systems, Inc.

What is DCTH?
Delcath Systems, Inc. Delcath Systems, Inc. (NASDAQ: DCTH) is a publicly traded specialty pharmaceutical and medical device company that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body.

I have found that this company has had two reverse splits; Dec 24, 2019 1:700 Stock Split, Oct 22, 2019 1:100 Stock Split. Reverse stock splits boost a company's share price. A higher share price is usually good, but the increase that comes from a reverse split is mostly an accounting trick. ... Whatever value it has is just distributed over fewer shares of stock, thus increasing the price. Anytime a company does a reverse split, it is a signal that a company is in distress.

My Thoughts For You
The Acronym of this company brings to mind what it could mean to those who invested. "Death Comes To Hodlers" I have read many comments about this company and they are not good. Check out the comments here.

This stock could bounce up as a fake out but history does repeat itself and so the story goes, I was and was no more.

Good Luck, Cheers!

Be sure to comment, follow, like, and check out my profile for more trade ideas!


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.